<DOC>
	<DOCNO>NCT02853916</DOCNO>
	<brief_summary>The objective trial confirm efficacy human brown seaweed powder explore dose-response relationship compare two different dos . The primary endpoint incremental area curve ( iAUC , mmol*min/L ) blood glucose .</brief_summary>
	<brief_title>Efficacy Brown Seaweed Powder Glycemic Control</brief_title>
	<detailed_description />
	<criteria>Males female age 1845 Normoglycemic ( fast blood glucose &lt; 5.6 mmol/L ) Body mass index ( BMI ) 18.529.9 kg/m2 Able consume bread product Exclusion Criteria Fasting blood glucose &gt; 5.6 mmol/L Systolic blood pressure &gt; 140 mmHg and/or diastolic blood pressure &gt; 90 mmHg Previous history cardiovascular disease , diabetes , liver kidney disease , inflammatory bowel disease , celiac disease , short bowel syndrome , malabsorptive syndrome , pancreatitis , gallbladder biliary disease Presence gastrointestinal disorder within past year Presence major gastrointestinal surgery Thyroid problem Smokers Consuming prescription nonprescription drug , herbal nutritional supplement know affect blood glucose could affect outcome study per investigator 's judgement Women currently pregnant lactating , use appropriate contraception method Excessive alcohol intake ( 2 drink per day 9 drink per week ) Allergic shellfish ( crab ) mollusc Weight gain loss least 10lbs previous three month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>